Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model

Journal of Periodontology

Volumn 75, Issue 10, 2004, Pages 1364-1370

  Pang, Eun Kyoung ^a   Im, Se Ung ^b   Kim, Chang Sung ^a   Choi, Seong Ho ^b   Chai, Jung Kiu ^a   Kim, Chong Kwan ^b   Han, Soo Boo ^c   Cho, Kyoo Sung ^b  

^a Seoul National University   (South Korea)

^b Yonsei University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Animal studies; Bone morphogenetic proteins; Bone regeneration; Collagen therapeutic use; Dose response; Periodontal regeneration; Tricalcium phosphate therapeutic use

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN; DRUG CARRIER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 4; RECOMBINANT GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE DENSITY; CALVARIA; DRUG EFFICACY; DRUG IMPLANTATION; HEALING; HISTOLOGY; HISTOMETRY; MALE; NONHUMAN; OSSIFICATION; OSTEOTOMY; RAT; RAT STRAIN; STATISTICAL ANALYSIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE DISEASES; BONE MORPHOGENETIC PROTEINS; CALCIUM PHOSPHATES; COLLAGEN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; GELATIN SPONGE, ABSORBABLE; HUMANS; MALE; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SKULL; TIME FACTORS; WOUND HEALING;

EID: 8744240478     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.10.1364     Document Type: Article

References (41)

1. Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899.
2. Kim CS, Choi SH, Choi BK, et al. The effect of recombinant human bone morphogenetic protein-4 on the osteoblastic differentiation of mouse calvarial cells affected by Porphyromonas gingivalis. J Periodontol 2002;73:1126-1132.
3. Ahn SH, Kim CS, Suk HJ, et al. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects. J Periodontol 2003;74:787-797.
4. Wikesjö UM, Guglielmoni P, Promsudthi A, et al. Periodontal repair in dogs: Effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999;26:392-400.
5. Choi SH, Kim CK, Cho KS, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72.
6. Sampath TK, Maliakal JC, Hauschka PV. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-20362.
7. Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R. Recombinant Vgr-1/BMP-6 expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994; 126: 1595-1609.
8. Urist MR, Nilsson O, Rasmussen J, et al. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop 1987;214:295-304.
9. Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger JO. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 1994;28: 1139-1147.
10. Urist MR, Lietze A, Dawson E. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop 1984;187:277-280.
11. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub RG, Ron E. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res 1994;28:1127-1138.
12. King GN, King N, Hughes FJ. Two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration in vivo. J Periodontal Res 1998;33: 226-236.
13. Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjö UM. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8:367-374.
14. Barboza EP, Duarte ME, Geolas L, Sorensen RG, Riedel GE, Wikesjö UM. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000;71:488-496.
15. Alam MI, Asahina I, Ohmamiuda K, Enomoto S. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes. J Biomed Mater Res 2001;54:129-138.
16. Gao TJ, Lindholm TS, Kommonen B, et al. Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J Biomed Mater Res 1996;32:505-512.
17. Alam MI, Asahina I, Ohmamiuda K, Takahashi K, Yokota S, Enomoto S. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 2001;22:1643-1651.
18. Laffargue P, Hildebrand HF, Rtaimate M, Frayssinet P, Amoureux JP, Marchandise X. Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects. Bone 1999;25(Suppl.):55S-58S.
19. Ohura K, Hamanishi C, Tanaka S, Matsuda N. Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rhBMP-2. J Biomed Mater Res 1999;44:168-175.
20. Sandhu HS, Kanim LE, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-2122.
21. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud TS. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 1994;76:827-838.
22. Tatakis DN, Koh A, Jin L, Wozney JM, Rohrer MD, Wikesjö UM. Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J Periodontal Res 2002;37:93-100.
23. Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 1982;196:100-109.
24. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop 1986;205:299-308.
25. Frame JW. A convenient animal model for testing bone substitute materials. J Oral Surg 1980;38:176-180.
26. Bays RA. Current concepts in bone grafting. In: Irby WB, Shelton DW, eds. Current Advances in Oral and Maxilofacial Surgery, vol. 4. St. Louis: The C.V. Mosby Company; 1983:109.
27. Higuchi T, Kinoshita A, Takahashi K, Oda S, Ishikawa I. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J Periodontol 1999;70: 1026-1031.
28. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1999;46:193-202.
29. Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop 1999;367(Suppl.): S95-S106.
30. Boden SD, Martin GJJ, Horton WC, Truss TL, Sandhu HS. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998; 11:95-101.
31. Zellin G, Linde A. Bone neogenesis in domes made of expanded polytetrafluoroethylene: Efficacy of rhBMP-2 to enhance the amount of achievable bone in rats. Plast Reconstr Surg 1999;103:1229-1237.
32. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci (USA) 1990;87:2220-2224.
33. Kanatani M, Sugimoto T, Kaji H, et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 1995;10:1681-1690.
34. Aspenberg P, Turek T. BMP-2 for intramuscular bone induction: Effect in squirrel monkeys is dependent on implantation site. Acta Orthop Scand 1996;67:3-6.
35. Sigurdsson TJ, Nygaard L, Tatakis DN, et al. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996;16:524-537.
36. Mao T, Wang C, Zhang S, et al. An experimental study on rhBMP-2 composite bone substitute for repairing craniomaxillary bone defects. Chin J Dent Res 1998;1:21-25.
37. Wu CH, Hara K, Ozawa H. Enhanced osteoinduction by intramuscular grafting of BMP-beta-TCP compound pellets into murine models. Arch Histol Cytol 1992;55:97-112.
38. Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg Am 1991;73:750-764.
39. Miyamoto S, Takaoka K, Okada T, et al. Polylactic acidpolyethylene glycol block copolymer. Clin Orthop 1993; 294:333-343.
40. Isaksson S, Alberius P, Klinge B. Influence of three alloplastic materials on calvarial bone healing. An experimental evaluation of HTR-polymer, lactomer beads, and a carrier gel. Int J Oral Maxillofac Surg 1993;22:375-381.
41. Kawamura M, Urist MR. Human fibrin is a physiologic delivery system for bone morphogenetic protein. Clin Orthop 1988;235:302-310.